Docetaxel anhydrous is a chemotherapy drug that is used to treat various types of cancer, including breast cancer, prostate cancer, and lung cancer. It is marketed under the trade name Taxotere by Sanofi-Aventis. Docetaxel anhydrous has the chemical name (2R,3S)-N-carboxy-3-phenylisoserine-N-tert-butoxycarbonyl-3'-tert-butoxycarbonyl-2'-phenylisoserine 3'-phenylisoserine ester with 5-20% anhydrous solvent, a molecular formula of C43H53NO14, formula weight of 806.88 g/mol and CAS No. 114977-28-5.
Top 10 Keywords related to Docetaxel Anhydrous from Google are:
Synonyms of Docetaxel Anhydrous are: Taxotere anhydrous, Docetaxel trihydrate, RP 56976
Health Benefits of Docetaxel Anhydrous: Docetaxel anhydrous is a taxane class chemotherapy drug that is used to treat various types of cancer, including breast cancer, prostate cancer, and lung cancer. It works by inhibiting the growth of cancerous cells by disrupting the microtubule network, which is essential for cell division. Docetaxel anhydrous can be used as a single agent or in combination with other chemotherapy drugs to improve treatment outcomes.
Potential Effects of Docetaxel Anhydrous: Docetaxel anhydrous has been found to be effective in the treatment of various types of cancer, including breast cancer, prostate cancer, and lung cancer. It has been shown to improve overall survival and progression-free survival in patients with these types of cancer. Docetaxel anhydrous is also being investigated for use in other types of cancer, including head and neck cancer and gastric cancer.
Product Mechanism of Action: Docetaxel anhydrous is a taxane class chemotherapy drug that works by disrupting the microtubule network, which is essential for cell division. It stabilizes microtubules, leading to the inhibition of cell division and the eventual death of cancerous cells. Docetaxel anhydrous also has antiangiogenic properties, inhibiting the formation of new blood vessels that supply nutrients and oxygen to tumors.
Safety: Docetaxel anhydrous is generally safe and well-tolerated in patients with cancer. The most common adverse reactions reported with the use of docetaxel anhydrous include neutropenia, fatigue, hair loss, peripheral neuropathy, nausea, and vomiting. More serious adverse reactions include myelosuppression, infections, hypersensitivity reactions, and fluid retention.
Side Effects: The side effects of docetaxel anhydrous depend on the dose and duration of treatment. Common side effects include neutropenia, fatigue, hair loss, peripheral neuropathy, nausea, and vomiting. More serious adverse
